|
|
News Breaks | | | | October 9, 2012 | | 07:39 EDT |  | PATH | NuPathe reducing workforce by 50%, delaying filing of IND application for NP202
As previously reported, on September 25, NuPathe Inc. entered into a Securities Purchase Agreement with certain qualified institutional purchasers and individual investors pursuant to which the Company agreed to sell to the Investors units of the Company’s securities for an aggregate purchase price of $28M. In connection with the Proposed Financing, the Company is undertaking certain cost containment measures in order to focus its expenditures on gaining FDA approval of NP101, securing commercial partners and select pre-launch activities. The cost containment measures include, among others: A 50% reduction in workforce; Reducing expenditures relating to commercialization activities for NP101 and the earlier stage product candidates; Delaying the filing of an Investigational New Drug application for NP202, the Company’s product candidate for the long-term treatment of schizophrenia and bipolar disorder, until a co-development partner is obtained; and the previously reported restructuring of the Company’s outstanding debt under its term loan facility. The Company believes that the proceeds to be received upon the closing of the Proposed Financing, together with the foregoing cost containment measures, will provide sufficient capital to fund operations into 4Q13. | |
|
News For PATH From The Last 14 Days Check below for free stories on PATH the last two weeks. |
|
|
| May 14, 2013 | | 07:38 EDT |  | PATH | NuPathe reports Q1 EPS (68c) with items, consensus (17c)
 Subscribe for More Information | | | May 13, 2013 | | 15:27 EDT | | PATH | Notable companies reporting after market close
Notable companies reporting before tomorrow's open, with earnings consensus, include AutoNavi Holdings (AMAP), consensus 19c; Hi-Crush Partners (HCLP), consensus 50c; Global Sources (GSOL), one estimate 17c; General Finance (GFN), one estimate 11c; NuPathe (PATH), consensus (17c). | | | 08:22 EDT | | PATH | NuPathe announces allowance of U.S. patent application for NP201
Subscribe for More Information | |
|
|
|
|
|
|
